Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application

Cancer Immunology, Immunotherapy

Volumn 53, Issue 8, 2004, Pages 705-714

  Trevor, Katrina T ^a   Cover, Cathleen ^a   Ruiz, Yvette W ^a   Akporiaye, Emmanuel T ^a   Hersh, Evan M ^a   Landais, Didier ^b   Taylor, Rachel R ^b   King, Alan D ^c   Walters, Richard E ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b IDM (Immune Designed Molecules)   (France)

^c Cyto Pulse Sciences   (United States)

Author keywords

Cancer; Dendritic cells; Electrofusion; Hybrids; Immunotherapy

Indexed keywords

ARTICLE; CANCER IMMUNOTHERAPY; CELL MATURATION; CELL STIMULATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; ELECTROFUSION (CELL); HUMAN; HUMAN CELL; HYBRID CELL; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; TUMOR CELL LINE;

EID: 3242666838     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-004-0512-1     Document Type: Article

References (37)

1. Akasaki Y, Kikuchi T, Homma S, Abe T, Kofe D, Ohno T (2001) Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J Immunother 24:106
2. Brossart P, Wirths S, Brugger W, Lothar K (2001) Dendritic cells in cancer vaccines. Exp Hem 29:1247
3. Chan RC, Xie H, Zhao GP, Xie Y (2002) Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes. Immunol Lett 3:101
4. Galea-Lauri J, Darling D, Mufti G, Harrison P, Farzaneh F (2002) Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunol Immunother 51:299
5. Goddard RV, Prentice AG, Copplestone JA, Kaminski ER (2002) In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia ehanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids. Clin Exp Immnol 131:82
6. Gong J, Chen D, Kashiwaba M, Kufe D (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinomas cells. Nat Med 3:558
7. Gong J, Avigan D, Chen D, Wu A, Koido S, Kashiwaba M, Kufe D (2000) Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc Natl Acad Sci U S A 97:2715
8. Gong J, Nikrui N, Chen D, Koido S, Wu Z, Tanaka Y, Cannistra S, Avigan D, Kufe D (2000) Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol 165:1705
9. Gong J, Koido S, Chen D, Tanaka Y, Huang L, Avigan D, Anderson K, Ohno T, Kufe D (2002) Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12. Blood 99:2512
10. Goxe B, Latour N, Chokri JP, Abastado JP, Salcedo M (2000) Simplified method to generate large quantities of dendritic cells suitable for clinical applications. Immunol Invest 29:319
11. Hayashi T, Tanaka H, Tanaka J, Wang R, Averbook BJ, Cohen PA, Shu S (2002) Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion. Clin Immunol 104:14
12. Holmes LM, Li J, Sticca RP, Wagner TE, Wei Y. (2001) A rapid, novel strategy to induce tumor cell-specific cytotoxic T lymphocyte responses using instant dendritomas. J Immunother 24:122
13. Hsueh EC, Essner R, Foshag LJ, Ollila DW, Gammon G, O'Day SJ, Boasberg PD, Stern SL, Ye X, Morton DL (2002) Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol 20:4549
14. Jaffee EM (1999) Immunotherapy of cancer. Ann N Y Acad Sci 886:67
15. Jaffee EM, Hruban RH, Biedrzycki B, Laheru D, Schepers K, Sauter PR, Goemann M, Coleman J, Grochow L, Donehower RC, Lillemoe KD, O'Reilly S, Abrams RA, Pardoll DM, Cameron JL, Yeo CJ (2001) Novel allogeneic granulocytemacrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol 19:145-156
16. Jantscheff P, Spagnoli G, Zajac P, Rochlitz CF (2002) Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells. Cancer Immunol Immunother 51:367
17. Kikuchi T, Akasaki Y, Irie M, Homma S, Abe T, Ohno T (2001) Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 50:337
18. Krause SW, Neumann C, Soruri A, Mayer S, Peters JH, Andreesen R (2002) The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells. J Immunother 25:421
19. Lee KH, Panelli MC, Kim CJ, Riker AI, Bettinotti MP, Roden MM, Fetsch P, Abati A, Rosenberg SA, Marincola FM (1998) Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination. J Immunol 161:4183
20. Lee AW, Truong T, Bickham K, Fonteneau JF, Larsson M, Da Silva I, Somersan S, Thomas EK, Bhardwaj N (2002) A clinical grade cocktail of cytokines and PGE(2) results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine 20[Suppl 4]:A8
21. Li J, Holmes LM, Franek KJ, Burgin KD, Wagner TE, Wei Y (2001) Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity. Cancer Immunol Immunother 50:456
22. Linder M, Schirrmacher V (2002) Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylene-glycol versus electro-fusion protocols. Euro J Clin Invest 32:207
23. Marten A, Renoth S, Heinicke T, Albers P, Pauli A, Mey U, Caspari R, Flieger D, Hanfland P, Von Ruecker A, Eis-Hubinger AM, Muller S, Schwaner I, Lohmann U, Heylmann G, Sauerbruch T, Schmidt Wolf IG (2003) Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma. Hum Gene Ther 14:483
24. Neil GA, Zimmermann U (1993) Electrofusion. Methods Enzymol 220:174
25. Orentas RJ, Schauer D, Bin Q, Johnson BD (2001) Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine. Cell Immunol 213:4
26. Parkhurst MR, DePan C, Riley JP, Rosenberg SA, Shu S (2003) Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC Class I and Class II molecules. J Immunol 170:5317
27. Schuler G, Schuler-Thurner B, Steinman RM (2003) The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15:138
28. Scott-Taylor TH, Pettengell R, Clarke I, Stuhler G, La Barthe MC, Walden P, Dalgleish AG (2000) Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines. Biochim Biophys Acta 1500:265
29. Siders WM, Vergilis KL, Johnson C, Shields J, Kaplan JM (2003) Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells. Mol Ther 7:498
30. Soruri A, Fayyazi A, Neumann C, Schlott T, Jung T, Matthes C, Zwirner J, Riggert J, Peters JH (2001) Ex vivo generation of human anti-melanoma autologous cytolytic T cells by dendritic cell/melanoma cell hybridomas. Cancer Immunol Immunother 50:307
31. Spisek R, Bretaudeau L, Barbieux I, Meflah K, Grégoire M (2001) Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use. Cancer Immunol Immunother 50:417
32. Steinman RM, Pope M (2002) Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 109:1519
33. Trevor KT, Hersh EM, Brailey J, Balloul JM, Acres B (2001) Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUCl and IL-2. Cancer Immunol Immunother 50:397
34. Wang J, Saffold S, Cao X, Krauss J, Chen W (1998) Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J Immunol 161:5516
35. Ward S, Casey D, Labarthe MC, Whelan M, Dalgleish A, Pandha H, Todryk S (2002) Immunotherapeutic potential of whole tumour cells. Cancer Immunol Immunother 51:351
36. Zhou Y, Bosch ML, Salgaller ML (2002) Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity. J Immunother 25:289
37. Zimmermann U (1982) Electric field-mediated fusion and related electrical phenomena. Biochim Biophys Acta 694:227